Denosumab as an add-on Neoadjuvant Treatment (GeparX)

Clinical trial NCT02682693 · COMPLETED

Trial details

NCT number: NCT02682693
Sponsor: GBG Forschungs GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Female NOS Tubular Breast Cancer Stage II Mucinous Breast Cancer Stage II Invasive Ductal Breast Cancer HER2 Positive Breast Cancer Inflammatory Breast Cancer Tubular Breast Cancer Stage III

Start date: 2017-02-13
Primary completion: 2019-12-31
Enrollment: 780

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.